Kathryn Romano, Chief Accounting Officer at Krystal Biotech, Inc. (KRYS), sold 2,500 shares at $130.00 ($325K) on 2024-01-22, disclosed to the SEC on 2024-01-24.
Scheduled sale ($325k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KRYS | SELL | 2025-02-28 | $131K | — | Filing → |
| KRYS | SELL | 2024-03-01 | $1.8M | — | Filing → |
| KRYS | SELL | 2024-03-01 | $1.4M | — | Filing → |